chr15-40624604-C-T

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_144508.5(KNL1):​c.4340C>T​(p.Thr1447Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000799 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000035 ( 0 hom. )

Consequence

KNL1
NM_144508.5 missense

Scores

4
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 0.305
Variant links:
Genes affected
KNL1 (HGNC:24054): (kinetochore scaffold 1) The protein encoded by this gene is a component of the multiprotein assembly that is required for creation of kinetochore-microtubule attachments and chromosome segregation. The encoded protein functions as a scaffold for proteins that influence the spindle assembly checkpoint during the eukaryotic cell cycle and it interacts with at least five different kinetochore proteins and two checkpoint kinases. In adults, this gene is predominantly expressed in normal testes, various cancer cell lines and primary tumors from other tissues and is ubiquitously expressed in fetal tissues. This gene was originally identified as a fusion partner with the mixed-lineage leukemia (MLL) gene in t(11;15)(q23;q14). Mutations in this gene cause autosomal recessive primary microcephaly-4 (MCPH4). Alternative splicing results in multiple transcript variants encoding different isoforms. Additional splice variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.021667928).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000513 (78/152174) while in subpopulation AFR AF= 0.00183 (76/41508). AF 95% confidence interval is 0.0015. There are 0 homozygotes in gnomad4. There are 35 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KNL1NM_144508.5 linkuse as main transcriptc.4340C>T p.Thr1447Ile missense_variant 10/26 ENST00000399668.7 NP_653091.3 Q8NG31-2
KNL1NM_170589.5 linkuse as main transcriptc.4418C>T p.Thr1473Ile missense_variant 11/27 NP_733468.3 Q8NG31-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KNL1ENST00000399668.7 linkuse as main transcriptc.4340C>T p.Thr1447Ile missense_variant 10/261 NM_144508.5 ENSP00000382576.3 Q8NG31-2

Frequencies

GnomAD3 genomes
AF:
0.000513
AC:
78
AN:
152056
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00184
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000882
AC:
22
AN:
249446
Hom.:
0
AF XY:
0.0000517
AC XY:
7
AN XY:
135348
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000496
GnomAD4 exome
AF:
0.0000349
AC:
51
AN:
1461652
Hom.:
0
Cov.:
34
AF XY:
0.0000289
AC XY:
21
AN XY:
727136
show subpopulations
Gnomad4 AFR exome
AF:
0.00120
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.000132
GnomAD4 genome
AF:
0.000513
AC:
78
AN:
152174
Hom.:
0
Cov.:
32
AF XY:
0.000470
AC XY:
35
AN XY:
74422
show subpopulations
Gnomad4 AFR
AF:
0.00183
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000785
Hom.:
0
Bravo
AF:
0.000612
ESP6500AA
AF:
0.000814
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000116
AC:
14
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJun 15, 2016The T1473I variant in the CASC5 gene has not been reported previously as a pathogenic variant nor as a benign polymorphism, to our knowledge. This variant is a non-conservative amino acid substitution of a polar Threonine with a non-polar Isoleucine at a residue that is not conserved across species. In silico analysis was inconsistent with regard to the effect this variant may have on the protein structure/function. The T1473I variant was not observed at any significant frequency in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. We interpret T1473I as a variant of unknown significance. -
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMar 24, 2014- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 16, 2022The c.4418C>T (p.T1473I) alteration is located in exon 11 (coding exon 10) of the KNL1 gene. This alteration results from a C to T substitution at nucleotide position 4418, causing the threonine (T) at amino acid position 1473 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
T;T;.
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.054
N
LIST_S2
Benign
0.66
T;T;T
M_CAP
Benign
0.0045
T
MetaRNN
Benign
0.022
T;T;T
MetaSVM
Benign
-1.1
T
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-2.5
D;.;D
REVEL
Benign
0.10
Sift
Uncertain
0.0050
D;.;D
Sift4G
Uncertain
0.0060
D;D;D
Polyphen
0.98
D;.;D
Vest4
0.12
MVP
0.41
MPC
0.17
ClinPred
0.064
T
GERP RS
4.2
Varity_R
0.091
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200605040; hg19: chr15-40916802; API